
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current VLS market cap is 99.22M. The company's latest EPS is AUD 0.1576 and P/E is 11.29.
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 47.13M | 57.25M | 66.93M | 74.53M | 79.59M |
Operating Income | 8.21M | 11.16M | 10.77M | 12.23M | 11.88M |
Net Income | 6.09M | 8.25M | 7.08M | 9.08M | 8.78M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 39.1M | 45.27M | 51.8M | 59.81M | 71.89M |
Total Liabilities | 14.66M | 14.85M | 15.3M | 16.48M | 19.61M |
Total Equity | 24.44M | 30.42M | 36.5M | 43.33M | 52.28M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | 7.54M | 5.89M | 2.78M | 12.98M | 6.16M |
Investing | -89k | -155k | -139k | -660k | -198k |
Financing | -3.03M | -4.39M | -3.11M | -2.88M | -2.99M |
Market Cap | 99.22M |
Price to Earnings Ratio | 11.29 |
Price to Sales Ratio | 1.25 |
Price to Cash Ratio | 3.47 |
Price to Book Ratio | 1.9 |
Dividend Yield | - |
Shares Outstanding | 55.74M |
Average Volume (1 week) | 16.93k |
Average Volume (1 Month) | 18.85k |
52 Week Change | -23.93% |
52 Week High | 2.46 |
52 Week Low | 1.705 |
Spread (Intraday) | 0.09 (5.08%) |
Company Name | Vita Life Sciences Limited |
Address |
unit 1/102 sydney, new south wales 2232 |
Website | https://www.vitalifesciences.com |
Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions